Or Refractory Classical Hodgkin Lymphoma

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2021-06-25
Clinical Trial Update: B-CD30 + Hodgkin Lymphoma International Multi-center Retrospective Study of Treatment Practices and Outcomes
A completed retrospective study assessing treatment practices and outcomes in classical Hodgkin lymphoma, including relapsed or refractory c…